January 20, 2025 - 23:45

Cecile Richards, who served as the president of Planned Parenthood from 2006 to 2018, has died at the age of 67. During her tenure, Richards was a prominent advocate for reproductive health care and played a crucial role in expanding access to essential services for millions of women across the United States. Under her leadership, Planned Parenthood became a key player in the national conversation surrounding women's rights and health care access.
Richards was known for her unwavering commitment to providing comprehensive health services, including cancer screenings, contraception, and sex education. She also fiercely defended the organization against political attacks and funding cuts, often testifying before Congress to advocate for reproductive rights. Her efforts not only strengthened Planned Parenthood's mission but also inspired a generation of activists to engage in the fight for women's health issues.
Her legacy will continue to influence the ongoing struggle for reproductive rights and access to health care for all individuals.
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...